{"id":"https://openalex.org/W3211925907","doi":"https://doi.org/10.3390/jpm11111211","title":"Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls","display_name":"Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls","alternate_titles":[],"publication_year":2021,"publication_date":"2021-11-16","ids":{"openalex":"https://openalex.org/W3211925907","doi":"https://doi.org/10.3390/jpm11111211","mag":"3211925907","pmid":"https://pubmed.ncbi.nlm.nih.gov/34834563","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8620404"},"language":"en","primary_location":{"id":"doi:10.3390/jpm11111211","doi":"https://doi.org/10.3390/jpm11111211","is_oa":true,"landing_page_url":"https://doi.org/10.3390/jpm11111211","pdf_url":"https://www.mdpi.com/2075-4426/11/11/1211/pdf?version=1637054490","source":{"id":"https://openalex.org/S2736780684","display_name":"Journal of Personalized Medicine","issn_l":"2075-4426","issn":["2075-4426"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Personalized Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3211925907"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2075-4426/11/11/1211/pdf?version=1637054490","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036497463","display_name":"Sara Bravaccini","orcid":"https://orcid.org/0000-0002-0075-8538","observed_orcids":["https://orcid.org/0000-0002-0075-8538"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Sara Bravaccini","raw_affiliation_strings":["IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via Maroncelli 40, 47014 Meldola, Italy"],"raw_orcid":"https://orcid.org/0000-0002-0075-8538","affiliations":[{"raw_affiliation_string":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via Maroncelli 40, 47014 Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036472378","display_name":"Roberta Maltoni","orcid":"https://orcid.org/0000-0003-0366-792X","observed_orcids":["https://orcid.org/0000-0003-0366-792X"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Roberta Maltoni","raw_affiliation_strings":["IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via Maroncelli 40, 47014 Meldola, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0366-792X","affiliations":[{"raw_affiliation_string":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via Maroncelli 40, 47014 Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036497463"],"corresponding_institution_ids":["https://openalex.org/I4210097834"],"apc_list":{"value":1800,"currency":"CHF","value_usd":1944},"apc_paid":{"value":1800,"currency":"CHF","value_usd":1944},"fwci":1.0759,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.71731378,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"11","issue":"11","first_page":"1211","last_page":"1211"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7060999870300293,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7060999870300293,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.05220000073313713,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03700000047683716,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trop2","display_name":"TROP2","score":0.984000027179718},{"id":"https://openalex.org/keywords/sacituzumab-govitecan","display_name":"sacituzumab govitecan","score":0.9319999814033508},{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.9710000157356262},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7789999842643738},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.4880000054836273},{"id":"https://openalex.org/keywords/regulatory-approval-delays","display_name":"regulatory approval delays","score":0.5680000185966492},{"id":"https://openalex.org/keywords/aifa","display_name":"AIFA","score":0.7329999804496765},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.5}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8189761638641357},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6332527995109558},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5633021593093872},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5558696389198303},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.5382096767425537},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5345494151115417},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4798414409160614},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.47656893730163574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4568844437599182},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.41909295320510864},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3746573030948639},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3620581328868866},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.23908811807632446},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16703388094902039},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.10296857357025146},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3390/jpm11111211","doi":"https://doi.org/10.3390/jpm11111211","is_oa":true,"landing_page_url":"https://doi.org/10.3390/jpm11111211","pdf_url":"https://www.mdpi.com/2075-4426/11/11/1211/pdf?version=1637054490","source":{"id":"https://openalex.org/S2736780684","display_name":"Journal of Personalized Medicine","issn_l":"2075-4426","issn":["2075-4426"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Personalized Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8620404","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8620404/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Pers Med","raw_type":"Text"},{"id":"pmid:34834563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34834563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of personalized medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3390/jpm11111211","doi":"https://doi.org/10.3390/jpm11111211","is_oa":true,"landing_page_url":"https://doi.org/10.3390/jpm11111211","pdf_url":"https://www.mdpi.com/2075-4426/11/11/1211/pdf?version=1637054490","source":{"id":"https://openalex.org/S2736780684","display_name":"Journal of Personalized Medicine","issn_l":"2075-4426","issn":["2075-4426"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Personalized Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3211925907.pdf","grobid_xml":"https://content.openalex.org/works/W3211925907.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W167359183","https://openalex.org/W1486001319","https://openalex.org/W1502025781","https://openalex.org/W1974320281","https://openalex.org/W1977814972","https://openalex.org/W1993127658","https://openalex.org/W2095432971","https://openalex.org/W2112245386","https://openalex.org/W2154495753","https://openalex.org/W2188271125","https://openalex.org/W2308070604","https://openalex.org/W2523492732","https://openalex.org/W2560635244","https://openalex.org/W2570352383","https://openalex.org/W2595349270","https://openalex.org/W2616923195","https://openalex.org/W2757511999","https://openalex.org/W2806941457","https://openalex.org/W2807992990","https://openalex.org/W2809327804","https://openalex.org/W2891825311","https://openalex.org/W2916220774","https://openalex.org/W2999417355","https://openalex.org/W2999659032","https://openalex.org/W3004452650","https://openalex.org/W3035644303","https://openalex.org/W3086278271","https://openalex.org/W3111523102","https://openalex.org/W3112701742","https://openalex.org/W3130879882","https://openalex.org/W3156142768","https://openalex.org/W3156985612","https://openalex.org/W3169973594","https://openalex.org/W3175784525"],"related_works":["https://openalex.org/W4302009910","https://openalex.org/W4324149036","https://openalex.org/W4311049979","https://openalex.org/W4401544048","https://openalex.org/W4401622458","https://openalex.org/W6901848673","https://openalex.org/W4200543295","https://openalex.org/W4285530812","https://openalex.org/W3165931631","https://openalex.org/W4285741464"],"abstract_inverted_index":{"Trop-2":[0,149],"is":[1,10,26,112,123,131,151],"an":[2,15],"ideal":[3],"candidate":[4],"for":[5,39,71,138],"targeted":[6],"therapeutics":[7],"because":[8,93],"it":[9,94],"a":[11,20,48,114,120,133],"transmembrane":[12],"protein":[13],"with":[14],"extracellular":[16],"domain":[17],"overexpressed":[18],"in":[19,28,90,117,135],"wide":[21],"variety":[22],"of":[23,74,142,148],"tumors,":[24],"and":[25,51,62,66,79,128,145],"upregulated":[27],"normal":[29],"cells.":[30],"Consequently,":[31],"several":[32],"Trop-2-targeted":[33],"drugs":[34],"have":[35],"recently":[36,57],"been":[37,98],"developed":[38],"clinical":[40,91],"use,":[41],"such":[42],"as":[43],"anti-Trop-2":[44],"antibodies.":[45],"Sacituzumab":[46],"govitecan,":[47],"Trop-2-directed":[49],"antibody":[50],"topoisomerase":[52],"inhibitor":[53],"drug":[54],"conjugate,":[55],"was":[56],"approved":[58,99,124],"by":[59,100,125],"the":[60,72,101,126,146],"Food":[61],"Drug":[63],"Administration":[64],"(FDA)":[65],"European":[67],"Medicines":[68],"Agency":[69],"(EMA)":[70],"treatment":[73,86],"metastatic":[75,80],"triple-negative":[76],"breast":[77],"cancer":[78],"urothelial":[81],"cancer.":[82],"In":[83,109],"Italy,":[84,110],"this":[85,111],"cannot":[87],"be":[88],"used":[89],"practice":[92],"has":[95],"not":[96,113],"yet":[97],"Agenzia":[102],"Italiana":[103],"del":[104],"Farmaco":[105],"(AIFA,":[106],"Rome,":[107],"Italy).":[108],"new":[115,121],"problem,":[116],"fact,":[118],"when":[119],"compound":[122],"U.S.":[127],"Europe,":[129],"there":[130],"often":[132],"delay":[134],"its":[136],"approval":[137],"use.":[139],"The":[140],"adoption":[141],"universal":[143],"guidelines":[144],"standardization":[147],"evaluation":[150],"urgently":[152],"needed.":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3211925907","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":9}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2021-11-22T00:00:00"}
